Evaluating the efficacy of memantine on improving cognitive functions in epileptic patients receiving anti-epileptic drugs: A double-blind placebo-controlled clinical trial (Phase IIIb pilot study).

Ann Indian Acad Neurol · 2016 · PMC4980957 · PMID 27570386

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

The Weshler's Memory Scale total score in memantine group improved significantly after 8 weeks ( P = 0.002) compared with baseline ( P = 0.873) and highly significant at the end of 16 th week ( P < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.